NEW YORK--(BUSINESS WIRE)--Pathway to Cures (P2C) announced today its investment of $500,000 in Five Liters, a subsidiary of Spark Biomedical, to develop therapies for treating inheritable blood and ...

The coagulation cascade is a finely balanced system essential for maintaining haemostasis, yet its disruption can lead to either a propensity for bleeding or an increased risk of clot formation.

Pathway to Cures Portfolio Company Spark Biomedical Receives Wellcome Leap Award for Advancements in Women’s Health: Heavy Menstrual Bleeding Pathway to Cures (P2C) congratulates Dr. Navid Khodaparast ...

NEW YORK--(BUSINESS WIRE)--Pathway to Cures (P2C) held its inaugural fund meeting on Saturday, October 28th in Chicago, Illinois. Pathway to Cures, an affiliate of the National Bleeding Disorders ...